









Markets
/
Stocks
/
nasdaq-lfmd
/

LifeMD Inc

LFMD

3.140USD

+0.370+13.36%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

146.27MMarket Cap

LossP/E TTM



LifeMD Inc

3.140

+0.370+13.36%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of LifeMD Inc

Currency: USD Updated: 2026-02-06

Key Insights

LifeMD Inc's fundamentals are relatively healthy, with low ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 84 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 9.25.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

LifeMD Inc's Score

Industry at a Glance

Industry Ranking

84 / 205

Overall Ranking

223 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

LifeMD Inc Highlights

StrengthsRisks

LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 78.48% year-on-year.

Fairly Valued

The company’s latest PE is -12.47, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 20.01M shares, decreasing 29.51% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 3.48K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 1.53.

Analyst Rating

Based on 8 analysts

Buy

Current Rating

9.250

Target Price

+233.94%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of LifeMD Inc is 7.36, ranking 89 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 60.17M, representing a year-over-year increase of 12.70%, while its net profit experienced a year-over-year increase of 22.43%.

Score

Industry at a Glance

Previous score

7.36

Change



Financials

6.95

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.64

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.03

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.94

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.24

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

LifeMD Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of LifeMD Inc is 7.91, ranking 52 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -12.47, which is -94.13% below the recent high of -0.73 and -425.92% above the recent low of -65.61.

Score

Industry at a Glance

Previous score

7.91

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 84/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of LifeMD Inc is 8.00, ranking 60 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 8.50, with a high of 15.00 and a low of 6.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 8 analysts

Buy

Current Rating

9.250

Target Price

+233.94%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

LifeMD Inc

LFMD

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of LifeMD Inc is 6.99, ranking 62 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 4.09 and the support level at 2.46, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.57

Change

0.42

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(1)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.109

Sell

RSI(14)

41.086

Neutral

STOCH(KDJ)(9,3,3)

29.523

Buy

ATR(14)

0.222

High Vlolatility

CCI(14)

-102.985

Sell

Williams %R

59.615

Sell

TRIX(12,20)

-0.657

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

3.088

Buy

MA10

3.247

Sell

MA20

3.509

Sell

MA50

3.561

Sell

MA100

4.704

Sell

MA200

7.181

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of LifeMD Inc is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 41.57%, representing a quarter-over-quarter decrease of 22.46%. The largest institutional shareholder is The Vanguard, holding a total of 2.02M shares, representing 4.20% of shares outstanding, with 1.51% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Schreiber (Justin)

2.85M

+7.23%

BlackRock Institutional Trust Company, N.A.

2.51M

+4.19%

The Vanguard Group, Inc.

Star Investors

2.23M

+6.75%

Galluppi (Stefan)

1.79M

+1.71%

Renaissance Technologies LLC

Star Investors

1.63M

+50.42%

Nuveen LLC

1.28M

+12.36%

State Street Investment Management (US)

1.14M

+0.39%

Geode Capital Management, L.L.C.

948.38K

+2.51%

Royce Investment Partners

Star Investors

814.45K

+5.71%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of LifeMD Inc is 3.63, ranking 120 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.91. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. LifeMD Inc’s latest ESG disclosure lags behind the Healthcare Equipment & Supplies industry average, suggesting potential exposures in governance structure, environmental management, or social responsibility that may amplify risk and warrant ongoing monitoring.